Suppr超能文献

阴离子磷脂在凝血因子Xa激活蛋白C及其在人血浆中抗凝功能表达中的催化作用。

The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma.

作者信息

Freyssinet J M, Toti-Orfanoudakis F, Ravanat C, Grunebaum L, Gauchy J, Cazenave J P, Wiesel M L

机构信息

Institut d'Hématologie et d'Immunologie, Faculté de Médecine Strasbourg, France.

出版信息

Blood Coagul Fibrinolysis. 1991 Dec;2(6):691-8. doi: 10.1097/00001721-199112000-00001.

Abstract

Phospholipids bearing a proportion of anionic species such as phosphatidylserine are necessary to promote the anticoagulant potential of the protein C pathway. Factor Xa (200 or 350 pM) was found to activate protein C in a thrombomodulin-independent reaction requiring only phospholipids in Al(OH)3,-adsorbed plasma resupplemented with physiological concentrations of protein C (70 nM) and protein S (130 nM). All experiments were performed in the presence of an excess of hirudin. The activity of activated protein C was assessed by the survival of factor Va. The optimal phospholipid concentration range was 5 to 25 microM with a proportion of phosphatidylserine of 50% (mol/mol) resulting in a half-life of factor Va of 7.5 min in the absence of protein S and 4.2 min in its presence. Dns-EGR-Xa, an inactive derivative of factor Xa, behaved as an apparent protector of factor Va. When replacing factor Xa, thrombin at 10 nM was not an efficient protein C activator in the absence of purified human placenta thrombomodulin. In the presence of 100 pM activated protein C, factor Va half-life was 2 min in the absence of protein S and 1.1 min in its presence in the above optimal phospholipid concentration range. The presence of protein S allowed reduction of phospholipid requirements. Annexin-V (placental anticoagulant protein-I), a potent phospholipid antagonist, fully protected factor Va from degradation by phospholipid-dependent mechanisms. Factor Va was partially protected in the plasma of a patient having experienced thrombosis associated with lupus-like anticoagulant and anti-phospholipid auto-antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

带有一定比例阴离子类物质(如磷脂酰丝氨酸)的磷脂对于促进蛋白C途径的抗凝潜力是必需的。研究发现,在补充了生理浓度的蛋白C(70 nM)和蛋白S(130 nM)的Al(OH)₃吸附血浆中,仅需磷脂,因子Xa(200或350 pM)就能在不依赖血栓调节蛋白的反应中激活蛋白C。所有实验均在过量水蛭素存在的情况下进行。通过因子Va的存活情况评估活化蛋白C的活性。最佳磷脂浓度范围为5至25 μM,磷脂酰丝氨酸比例为50%(mol/mol)时,在无蛋白S的情况下因子Va半衰期为7.5分钟,有蛋白S时为4.2分钟。Dns - EGR - Xa是因子Xa的无活性衍生物,表现为因子Va的明显保护剂。当替代因子Xa时,在没有纯化的人胎盘血栓调节蛋白的情况下,10 nM的凝血酶不是有效的蛋白C激活剂。在上述最佳磷脂浓度范围内,存在100 pM活化蛋白C时,无蛋白S时因子Va半衰期为2分钟,有蛋白S时为1.1分钟。蛋白S的存在可降低对磷脂的需求。膜联蛋白V(胎盘抗凝蛋白 - I)是一种有效的磷脂拮抗剂,能完全保护因子Va不被磷脂依赖性机制降解。在一名患有与狼疮样抗凝物和抗磷脂自身抗体相关血栓形成的患者血浆中,因子Va受到部分保护。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验